Calithera Biosciences, Inc.
Calithera Biosciences, Inc., a clinical-stage bio-pharmaceutical company, focuses on the discovery and development of small molecule compounds for tumor metabolism and tumor immunology targets for the treatment of cancer in the United States. The company…
Biotechnology
US, South San Francisco [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared Calithera Biosciences, Inc. (CALA) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - - Average | - - | - - | - - | 667,459.85 | 23,097.57 | 2,605.62 | 983.73 | 812.44 | 0.00 | 23.8290 | 58.24 | -0.4040 | -15.7521 | -0.07 | -0.66 | 6.2725 | - - | |
| Maximum | - - | - - | - - | 66,761,212.00 | 1,187,075.00 | 264,468.00 | 99,050.00 | 262,089.00 | 0.02 | 1,336.3467 | 3,715.80 | 3.0051 | 85.3485 | 0.40 | 2.21 | 61.5621 | - - | |
| Minimum | - - | - - | - - | 0.00 | -5.00 | -10,603.00 | -56,335.00 | -50,658.00 | 0.00 | -233.7460 | -132.82 | -101.7758 | -1,444.7800 | -1.56 | -84.15 | 0.0000 | - - | |
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.